Schrodinger, Inc. Operating Income 2019-2024 | SDGR
Schrodinger, Inc. operating income from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Schrodinger, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-177 |
| 2022 | $-147 |
| 2021 | $-111 |
| 2020 | $-61 |
| 2019 | $-39 |
| 2018 | $-28 |
| Schrodinger, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-68 |
| 2024-06-30 | $-53 |
| 2024-03-31 | $-67 |
| 2023-12-31 | $-30 |
| 2023-09-30 | $-56 |
| 2023-06-30 | $-61 |
| 2023-03-31 | $-31 |
| 2022-12-31 | $-29 |
| 2022-09-30 | $-46 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-29 |
| 2021-12-31 | $-23 |
| 2021-09-30 | $-35 |
| 2021-06-30 | $-30 |
| 2021-03-31 | $-24 |
| 2020-12-31 | $-17 |
| 2020-09-30 | $-15 |
| 2020-06-30 | $-17 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-11 |
| 2019-06-30 | $-14 |
| 2019-03-31 | $-6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||